|
![]() |
|||
|
||||
OverviewThe recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This Element highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management. Full Product DetailsAuthor: Matthew Lee (Montefiore Medical Center and Albert Einstein College of Medicine) , Fawzi Abu Rous (Henry Ford Health System) , Alain Borczuk (Weill Cornell Medicine) , Stephen Liu (Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC)Publisher: Cambridge University Press Imprint: Cambridge University Press Dimensions: Width: 15.20cm , Height: 0.70cm , Length: 22.70cm Weight: 0.160kg ISBN: 9781009336130ISBN 10: 1009336134 Pages: 75 Publication Date: 02 February 2023 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |